16-69330536-G-C

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_022341.2(PDF):​c.35C>G​(p.Pro12Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000156 in 1,478,410 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00016 ( 0 hom. )

Consequence

PDF
NM_022341.2 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.29

Publications

0 publications found
Variant links:
Genes affected
PDF (HGNC:30012): (peptide deformylase, mitochondrial) Protein synthesis proceeds after formylation of methionine by methionyl-tRNA formyl transferase (FMT) and transfer of the charged initiator f-met tRNA to the ribosome. In eubacteria and eukaryotic organelles the product of this gene, peptide deformylase (PDF), removes the formyl group from the initiating methionine of nascent peptides. In eubacteria, deformylation of nascent peptides is required for subsequent cleavage of initiating methionines by methionine aminopeptidase. The discovery that a natural inhibitor of PDF, actinonin, acts as an antimicrobial agent in some bacteria has spurred intensive research into the design of bacterial-specific PDF inhibitors. In human cells, only mitochondrial proteins have N-formylation of initiating methionines. Protein inhibitors of PDF or siRNAs of PDF block the growth of cancer cell lines but have no effect on normal cell growth. In humans, PDF function may therefore be restricted to rapidly growing cells. [provided by RefSeq, Nov 2008]
COG8 (HGNC:18623): (component of oligomeric golgi complex 8) This gene encodes a protein that is a component of the conserved oligomeric Golgi (COG) complex, a multiprotein complex that plays a structural role in the Golgi apparatus, and is involved in intracellular membrane trafficking and glycoprotein modification. Mutations in this gene cause congenital disorder of glycosylation, type IIh, a disease that is characterized by under-glycosylated serum proteins, and whose symptoms include severe psychomotor retardation, failure to thrive, seizures, and dairy and wheat product intolerance. [provided by RefSeq, Jul 2008]
COG8 Gene-Disease associations (from GenCC):
  • COG8-congenital disorder of glycosylation
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.024188906).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDFNM_022341.2 linkc.35C>G p.Pro12Arg missense_variant Exon 1 of 2 ENST00000288022.2 NP_071736.1 Q9HBH1A0A024R6Y3
COG8NM_032382.5 linkc.*26+277C>G intron_variant Intron 5 of 5 ENST00000306875.10 NP_115758.3 Q96MW5A0A024R6Z6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDFENST00000288022.2 linkc.35C>G p.Pro12Arg missense_variant Exon 1 of 2 1 NM_022341.2 ENSP00000288022.1 Q9HBH1
COG8ENST00000306875.10 linkc.*26+277C>G intron_variant Intron 5 of 5 1 NM_032382.5 ENSP00000305459.6 Q96MW5B4DYU2
ENSG00000272617ENST00000562949.1 linkc.352-1357C>G intron_variant Intron 1 of 1 3 ENSP00000457718.1 H3BUN2
COG8ENST00000562595.5 linkc.548+4790C>G intron_variant Intron 3 of 3 5 ENSP00000456705.1 H3BSH5

Frequencies

GnomAD3 genomes
AF:
0.0000921
AC:
14
AN:
152042
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000775
AC:
6
AN:
77394
AF XY:
0.0000894
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000176
Gnomad OTH exome
AF:
0.000436
GnomAD4 exome
AF:
0.000163
AC:
216
AN:
1326368
Hom.:
0
Cov.:
32
AF XY:
0.000174
AC XY:
114
AN XY:
654510
show subpopulations
African (AFR)
AF:
0.0000757
AC:
2
AN:
26406
American (AMR)
AF:
0.00
AC:
0
AN:
26698
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23176
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29596
South Asian (SAS)
AF:
0.00
AC:
0
AN:
73050
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
32898
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3924
European-Non Finnish (NFE)
AF:
0.000199
AC:
210
AN:
1055590
Other (OTH)
AF:
0.0000727
AC:
4
AN:
55030
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000921
AC:
14
AN:
152042
Hom.:
0
Cov.:
33
AF XY:
0.0000808
AC XY:
6
AN XY:
74266
show subpopulations
African (AFR)
AF:
0.0000966
AC:
4
AN:
41426
American (AMR)
AF:
0.0000655
AC:
1
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
67974
Other (OTH)
AF:
0.00
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000680

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 16, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.35C>G (p.P12R) alteration is located in exon 1 (coding exon 1) of the PDF gene. This alteration results from a C to G substitution at nucleotide position 35, causing the proline (P) at amino acid position 12 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
0.024
DANN
Benign
0.41
DEOGEN2
Benign
0.0037
T
Eigen
Benign
-2.0
Eigen_PC
Benign
-2.1
FATHMM_MKL
Benign
0.0082
N
LIST_S2
Benign
0.30
T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.024
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.34
N
PhyloP100
-1.3
PrimateAI
Uncertain
0.71
T
PROVEAN
Benign
-0.070
N
REVEL
Benign
0.013
Sift
Benign
0.44
T
Sift4G
Benign
0.94
T
Polyphen
0.0
B
Vest4
0.16
MutPred
0.51
Gain of helix (P = 0.0082);
MVP
0.44
MPC
0.40
ClinPred
0.046
T
GERP RS
-7.0
PromoterAI
0.073
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.030
gMVP
0.41
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs960880193; hg19: chr16-69364439; API